Orogen Therapeutics
PrivateLast Round
Seed
Jun 16, 2023
Total Funding Raised
$18.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Orogen Therapeutics is a biotechnology company that develops small-molecule therapies using a proprietary AI-enabled DNA-encoded library (DEL) platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orogen Therapeutics Comparables
Compare Orogen Therapeutics with similar companies based on industry and business-model similarity.
Orogen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 16, 2023 |
Orogen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anterra Capital | Seed |
| Novalis LifeSciences | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 57% MoM.
- Feb 1, 2026
Monthly visitors grew 264% MoM, reaching 1.5K.
Orogen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orogen Therapeutics's valuation, stock price, and market status.
Is Orogen Therapeutics a public or private company?
Orogen Therapeutics is a private company.
What is the current stock price of Orogen Therapeutics?
Orogen Therapeutics is a private company, so its shares have no public market price. Caplight tracks Orogen Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orogen Therapeutics worth (valuation)?
Valuation information for Orogen Therapeutics is not publicly available.
Can I buy Orogen Therapeutics stock?
Orogen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orogen Therapeutics's last funding round?
Orogen Therapeutics's most recent funding round was Seed on June 16, 2023.
Who are the main investors in Orogen Therapeutics?
Key investors in Orogen Therapeutics include Anterra Capital, Novalis LifeSciences.
Will Orogen Therapeutics IPO soon?
No public IPO plans have been announced for Orogen Therapeutics.
How can I track Orogen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Orogen Therapeutics's shares on secondary markets.